Regulon

Regulon: R-553

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
212.853213Pr-12Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
7005 ENSG00000007866 TEAD3 Q99594
30846 ENSG00000024422 EHD2 Q9NZN4
5566 ENSG00000072062 PRKACA P17612
9322 ENSG00000125733 TRIP10 W4VSQ9
6238 ENSG00000125844 RRBP1 Q9P2E9
54795 ENSG00000130529 TRPM4 Q8TD43
3911 ENSG00000130702 LAMA5 O15230
4000 ENSG00000160789 LMNA P02545
4665 ENSG00000166886 NAB2 Q15742
4862 ENSG00000170485 NPAS2 Q99743
54961 ENSG00000172830 SSH3 Q8TE77
1717 ENSG00000172893 DHCR7 B4E1K5
23612 ENSG00000174307 PHLDA3 Q9Y5J5
8061 ENSG00000175592 FOSL1 P15407
977 ENSG00000177697 CD151 A0A024RCB3
79642 ENSG00000180801 ARSJ Q5FYB0
4059 ENSG00000187244 BCAM P50895
29780 ENSG00000188677 PARVB Q9HBI1
2050 ENSG00000196411 EPHB4 P54760
51232 ENSG00000277354 CRIM1 Q53TH9
22904 ENSG00000278788 SBNO2 Q9Y2G9

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
VANDETANIBEPHA2Small moleculeINHIBITORTyrosine-protein kinase SRC inhibitor42
TESEVATINIBERBB2Small moleculeINHIBITOREphrin type-B receptor 4 inhibitor32
JI-101PDGFRBSmall moleculeINHIBITOREphrin type-B receptor 4 inhibitor20
TG100-801EPHB4Small moleculeINHIBITORSRC inhibitor20
OCRIPLASMINLAMA2EnzymePROTEOLYTIC ENZYMEFibronectin proteolytic enzyme40
GSK-690693PRKACBSmall moleculeINHIBITORProtein kinase C (PKC) inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-553

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-07531ANO7down-regulatesZNF263activatesR-553203Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

VANDETANIB, TESEVATINIB, JI-101, TG100-801, OCRIPLASMIN, GSK-690693

CMF-09599OR9G9up-regulatesZNF263activatesR-553205Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

VANDETANIB, TESEVATINIB, JI-101, TG100-801, OCRIPLASMIN, GSK-690693

CMF-26305CHGBup-regulatesZNF263activatesR-553202Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

VANDETANIB, TESEVATINIB, JI-101, TG100-801, OCRIPLASMIN, GSK-690693